Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2015

01.05.2015 | Original Article – Clinical Oncology

First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database

verfasst von: Christoph Oing, Anja Lorch, Carsten Bokemeyer, Friedemann Honecker, Jörg Beyer, Lars Arne Berger, Karin Oechsle

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively analyze clinical characteristics, prognostic factors, and optimal treatment of patients with bone metastases (BM) of germ cell tumors (GCT) at first relapse.

Methods

One hundred and four GCT patients with BM were identified from the IPFSG database containing 1,594 patients at first relapse. Within this database, all patients experienced unequivocal relapse/progression after cisplatin-based chemotherapy and had received either conventional (CD-CTX) or high-dose chemotherapy (HD-CTX) as first salvage treatment.

Results

At relapse, eight patients (8 %) had BM only, concomitant relapse with lung, brain, liver and/or nodal metastases were present in 40 (39 %), 6 (6 %), 27 (26 %), and 69 (66 %) pts, respectively. Patients clustered over all IPFSG subgroups, and the IPFSG score could be confirmed. Salvage treatment was CD-CTX in 35 and HD-CTX in 69 patients. Overall response (CR, PR) rate to salvage chemotherapy was 81 % (HD-CTX) versus 43 % (CD-CTX; p < 0.001). Median follow-up was 14 months (mos; range 1–161). Both, median PFS and OS, were higher after HD-CTX compared to CD-CTX [PFS 9 (95 % CI 6–12) vs. 5 (3–7) mos (p < 0.01); OS 18 (12–24) vs. 13 (8–18) mos (p = 0.078)].

Conclusions

GCT patients relapsing with BM have a dismal outcome. Retrospectively, first salvage HD-CTX seems to improve treatment response and outcome. Further evaluation of characteristics and treatment of GCT patients with BM is warranted.
Literatur
Zurück zum Zitat Aldejmah A, Soulières D, Saad F (2007) Isolated solitary bony metastasis of a nonseminomatous germ cell tumor. Can J Urol 14:3458–3460PubMed Aldejmah A, Soulières D, Saad F (2007) Isolated solitary bony metastasis of a nonseminomatous germ cell tumor. Can J Urol 14:3458–3460PubMed
Zurück zum Zitat Arnold PM, Morgan CJ, Morantz RA et al (2000) Metastatic testicular cancer presenting as spinal cord compression: report of two cases. Surg Neurol 54:27–33CrossRefPubMed Arnold PM, Morgan CJ, Morantz RA et al (2000) Metastatic testicular cancer presenting as spinal cord compression: report of two cases. Surg Neurol 54:27–33CrossRefPubMed
Zurück zum Zitat Asthana AK, Singh OP, Pant GC, Agrawal MS (1988) Seminoma of testis with unusual bone metastasis. Br J Urol 62:380–381CrossRefPubMed Asthana AK, Singh OP, Pant GC, Agrawal MS (1988) Seminoma of testis with unusual bone metastasis. Br J Urol 62:380–381CrossRefPubMed
Zurück zum Zitat Benedetti G, Rastelli F, Fedele M et al (2006) Presentation of nonseminomatous germ cell tumor of the testis with symptomatic solitary bone metastasis. A case report with review of the literature. Tumori 92:433–436PubMed Benedetti G, Rastelli F, Fedele M et al (2006) Presentation of nonseminomatous germ cell tumor of the testis with symptomatic solitary bone metastasis. A case report with review of the literature. Tumori 92:433–436PubMed
Zurück zum Zitat Beyer J, Albers P, Altena R et al (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24:878–888CrossRefPubMedCentralPubMed Beyer J, Albers P, Altena R et al (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24:878–888CrossRefPubMedCentralPubMed
Zurück zum Zitat Bosco P, Bihrle W 3rd, Malone MJ, Silverman ML (1994) Primary skeletal metastasis of a nonseminomatous germ cell tumor. Urology 43:564–566CrossRefPubMed Bosco P, Bihrle W 3rd, Malone MJ, Silverman ML (1994) Primary skeletal metastasis of a nonseminomatous germ cell tumor. Urology 43:564–566CrossRefPubMed
Zurück zum Zitat Collette L, Sylvester RJ, Stenning SP et al (1999) Impact of the treating institution on survival of patients with “poor-prognosis” metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 91:839–846CrossRefPubMed Collette L, Sylvester RJ, Stenning SP et al (1999) Impact of the treating institution on survival of patients with “poor-prognosis” metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 91:839–846CrossRefPubMed
Zurück zum Zitat Einhorn LH (2012) Salvage chemotherapy for patients with germ cell tumors: is there a best regimen? J Clin Oncol 30:771–772CrossRefPubMed Einhorn LH (2012) Salvage chemotherapy for patients with germ cell tumors: is there a best regimen? J Clin Oncol 30:771–772CrossRefPubMed
Zurück zum Zitat Fizazi K, Gravis G, Flechon A et al (2014) Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial. Ann Oncol 25:987–991CrossRefPubMed Fizazi K, Gravis G, Flechon A et al (2014) Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial. Ann Oncol 25:987–991CrossRefPubMed
Zurück zum Zitat International Germ Cell Consensus Classification (1997) A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594–603 International Germ Cell Consensus Classification (1997) A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594–603
Zurück zum Zitat Jamal-Hanjani M, Karpathakis A, Kwan A et al (2013) Bone metastases in germ cell tumours: lessons learnt from a large retrospective study. BJU Int 112:176–181CrossRefPubMed Jamal-Hanjani M, Karpathakis A, Kwan A et al (2013) Bone metastases in germ cell tumours: lessons learnt from a large retrospective study. BJU Int 112:176–181CrossRefPubMed
Zurück zum Zitat Johnson DE, Appelt G, Samuels ML, Luna M (1976) Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology 8:234–239CrossRefPubMed Johnson DE, Appelt G, Samuels ML, Luna M (1976) Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology 8:234–239CrossRefPubMed
Zurück zum Zitat Kollmannsberger C, Honecker F, Bokemeyer C (2008) Pharmacotherapy of relapsed metastatic testicular cancer. Expert Opin Pharmacother 9:2259–2272CrossRefPubMed Kollmannsberger C, Honecker F, Bokemeyer C (2008) Pharmacotherapy of relapsed metastatic testicular cancer. Expert Opin Pharmacother 9:2259–2272CrossRefPubMed
Zurück zum Zitat Koychev D, Oechsle K, Bokemeyer C, Honecker F (2011) Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update: treatment of relapsed germ cell tumours. Int J Androl 34:e266–e273CrossRefPubMed Koychev D, Oechsle K, Bokemeyer C, Honecker F (2011) Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update: treatment of relapsed germ cell tumours. Int J Androl 34:e266–e273CrossRefPubMed
Zurück zum Zitat Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 53:497–513CrossRefPubMed Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 53:497–513CrossRefPubMed
Zurück zum Zitat Lorch A, Beyer J, Bascoul-Mollevi C et al (2010) Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906–4911CrossRefPubMed Lorch A, Beyer J, Bascoul-Mollevi C et al (2010) Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906–4911CrossRefPubMed
Zurück zum Zitat Lorch A, Bascoul-Mollevi C, Kramar A et al (2011) Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol 29:2178–2184CrossRefPubMed Lorch A, Bascoul-Mollevi C, Kramar A et al (2011) Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol 29:2178–2184CrossRefPubMed
Zurück zum Zitat Lorch A, Kleinhans A, Kramar A et al (2012) Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J Clin Oncol 30:800–805CrossRefPubMed Lorch A, Kleinhans A, Kramar A et al (2012) Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J Clin Oncol 30:800–805CrossRefPubMed
Zurück zum Zitat Miyake M, Hirayama A, Matsushita C et al (2005) A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy. Hinyokika Kiyo 51:825–829PubMed Miyake M, Hirayama A, Matsushita C et al (2005) A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy. Hinyokika Kiyo 51:825–829PubMed
Zurück zum Zitat Nachankar A, Krishnatry R, Joshi A et al (2013) Primary mediastinal seminoma; resistance and relapse: an aggressive entity. Indian J Med Paediatr Oncol 34:309CrossRefPubMedCentralPubMed Nachankar A, Krishnatry R, Joshi A et al (2013) Primary mediastinal seminoma; resistance and relapse: an aggressive entity. Indian J Med Paediatr Oncol 34:309CrossRefPubMedCentralPubMed
Zurück zum Zitat Oechsle K, Bokemeyer C, Kollmannsberger C et al (2012) Bone metastases in germ cell tumor patients. J Cancer Res Clin Oncol 138:947–952CrossRefPubMed Oechsle K, Bokemeyer C, Kollmannsberger C et al (2012) Bone metastases in germ cell tumor patients. J Cancer Res Clin Oncol 138:947–952CrossRefPubMed
Zurück zum Zitat Oldenburg J, Fosså SD, Nuver J et al (2013) Testicular seminoma and non-seminoma: eSMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(suppl 6):vi125–vi132CrossRefPubMed Oldenburg J, Fosså SD, Nuver J et al (2013) Testicular seminoma and non-seminoma: eSMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(suppl 6):vi125–vi132CrossRefPubMed
Zurück zum Zitat Ozan E, Oztekin O, Kozacioglu Z et al (2009) Metastatic testicular germ cell tumor presenting with abdominal pain: CT and MRI findings. JBR-BTR 92:256–258PubMed Ozan E, Oztekin O, Kozacioglu Z et al (2009) Metastatic testicular germ cell tumor presenting with abdominal pain: CT and MRI findings. JBR-BTR 92:256–258PubMed
Zurück zum Zitat Pico J-L, Rosti G, Kramar A et al (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152–1159CrossRefPubMed Pico J-L, Rosti G, Kramar A et al (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152–1159CrossRefPubMed
Zurück zum Zitat Uygun K, Karagol H, Kocak Z et al (2006) Isolated bone metastasis in testicular germ cell tumors: a case report and review of the literature. Onkologie 29:93–95CrossRefPubMed Uygun K, Karagol H, Kocak Z et al (2006) Isolated bone metastasis in testicular germ cell tumors: a case report and review of the literature. Onkologie 29:93–95CrossRefPubMed
Zurück zum Zitat Watanabe M, Kamai T, Masuda A et al (2004) A case report: testicular pure seminoma metastasized to costal bone after 2 years post-operatively. Hinyokika Kiyo 50:505–509PubMed Watanabe M, Kamai T, Masuda A et al (2004) A case report: testicular pure seminoma metastasized to costal bone after 2 years post-operatively. Hinyokika Kiyo 50:505–509PubMed
Zurück zum Zitat Wudhikarn K, Colling CW, Robinson RA, Vaena DA (2013) Solitary bony metastasis in seminoma. J Clin Oncol 31:e259–e261CrossRefPubMed Wudhikarn K, Colling CW, Robinson RA, Vaena DA (2013) Solitary bony metastasis in seminoma. J Clin Oncol 31:e259–e261CrossRefPubMed
Metadaten
Titel
First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database
verfasst von
Christoph Oing
Anja Lorch
Carsten Bokemeyer
Friedemann Honecker
Jörg Beyer
Lars Arne Berger
Karin Oechsle
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1876-z

Weitere Artikel der Ausgabe 5/2015

Journal of Cancer Research and Clinical Oncology 5/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.